Zoetis. has been granted a patent for a vaccine composition against Porcine Epidemic Diarrhea Virus (PEDV), utilizing novel nucleotide sequences. The vaccine is designed to protect swine from various PEDV strains and associated symptoms, with efficacy demonstrated in single or two-dose programs. GlobalData’s report on Zoetis gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Zoetis, Personalized cancer vaccines was a key innovation area identified from patents. Zoetis's grant share as of June 2024 was 53%. Grant share is based on the ratio of number of grants to total number of patents.
Vaccine for porcine epidemic diarrhea virus (pedv)
The granted patent US12005113B2 presents a vaccine composition designed to protect swine from porcine epidemic diarrhea virus (PEDV). The composition includes an isolated PEDV encoded by specific DNA polynucleotide sequences (SEQ ID NO: 36 or SEQ ID NO: 37) and a carrier. This vaccine is formulated to provide protection against both variant and prototype strains of PEDV, effectively preventing or treating various symptoms associated with the infection. These symptoms include dehydration, fever, diarrhea, vomiting, poor lactational and reproductive performance, mortality, and weight loss. The vaccine is applicable to various swine categories, including sows, gilts, boars, hogs, and piglets, and can be administered in either a single or two-dose regimen, with a minimum effective dose of approximately 10^4 log10TCID50 per dose.
Further detailing the administration protocols, the patent specifies that in a two-dose program, the first dose should be given when piglets are between 1 to 7 days old, followed by a second dose administered at 2 to 5 weeks of age. Alternatively, the vaccine can also be effective in a single-dose program, which is recommended to be administered when piglets are between 1 to 21 days old. This innovative vaccine composition aims to enhance the health and productivity of swine by mitigating the impacts of PEDV, a significant concern in the swine industry.
To know more about GlobalData’s detailed insights on Zoetis, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
